Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

AAZTA-5: a new kit-type chelator for Lu-177 and Sc-44 with theranostic application in conjunction with DATA-5m for Ga-68

Jean-Philippe Sinnes, Ana De La Fuente Joaniquet, Doris Wiebe, Sven Boehland and Frank Roesch
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1069;
Jean-Philippe Sinnes
1Gutenberg-Universität Mainz Mainz Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana De La Fuente Joaniquet
1Gutenberg-Universität Mainz Mainz Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Doris Wiebe
1Gutenberg-Universität Mainz Mainz Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Boehland
1Gutenberg-Universität Mainz Mainz Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Roesch
1Gutenberg-Universität Mainz Mainz Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1069

Objectives Chelators for theranostic application provide access to tracers for imaging and therapy. The main representative is DOTA, whose conjuagtes like DOTA-TOC however are labeled under harsh conditions. The aim of this work was the development of a chelator and it’s TOC-derivative, that is capable of kit-type labeling (RT, pH 4.5-5.5). Both should be evaluated with Lu-177 as well as Sc-44 among kit-type labeling conditions.

Methods The bifunctional chelator AAZTA-5 (6-Amino-6-(5-methoxy-5-oxopentyl)-1,4-diacepine-tetraacetate) was synthesized in a 5-step synthesis and further coupled with TOC in 3 steps. Both derivatives were characterized and labeled at room temperature with Lu-177, Sc-44 and Ga-68 varying pH, time and chelator concentration. Complex stabilities against PBS-buffer, human serum, DTPA and EDTA were tested and challenge studies against iron were performed. For comparison analog experiments were performed with the bifunctional chelator DATA-5m (6-Methylamino-6-(5-methoxy-5-oxopentyl)-1,4-diacepine-triacetate) for Ga-68 and with a DOTA analog (5-methoxy-5-oxopentyl-DO3A) with Lu-177, Sc-44 and Ga-68.

Results Labeling studies of AAZTA-5 and AAZTA-5-TOC with all 3 radiometals showed quantitative yields at room temperature within minutes (< 5 min), whereas the DOTA derivative couldn’t reach these results with Lu-177 and Sc-44 below 90 °C (< 10 min). Increasing stability of the complexes was found in the order Ga < Lu < Sc, respectively. Ga-68-DATA-5m and Ga-68-DATA-5m-TOC as well showed quantitative labeling yields greater 95 % after 3 min and maximum stabilities (over 90 % (intact complex) after 120 min in all media).

Conclusions The bifunctional chelator AAZTA-5 is able of complexing Sc-44, Ga-68 and Lu-177. In a proof-of-principle study AAZTA-5 showed the capability of adding a targeting vector to the binding side without losing the ability of kit-type labeling. AAZTA-5 and AAZTA-5-TOC showed quanititative labeling under mild conditions as well as high complex stabilities. Especially the stability for Sc-44 seems to be resilient enough for in vivo application. The AAZTA-5 is suitable forming a chelator couple with the DATA-5m, which opens a wide spectrum for the theranostics through kit-type labeling.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
AAZTA-5: a new kit-type chelator for Lu-177 and Sc-44 with theranostic application in conjunction with DATA-5m for Ga-68
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
AAZTA-5: a new kit-type chelator for Lu-177 and Sc-44 with theranostic application in conjunction with DATA-5m for Ga-68
Jean-Philippe Sinnes, Ana De La Fuente Joaniquet, Doris Wiebe, Sven Boehland, Frank Roesch
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1069;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
AAZTA-5: a new kit-type chelator for Lu-177 and Sc-44 with theranostic application in conjunction with DATA-5m for Ga-68
Jean-Philippe Sinnes, Ana De La Fuente Joaniquet, Doris Wiebe, Sven Boehland, Frank Roesch
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1069;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Novel Radiochemistry & Chelation Posters

  • Radiolabeling and biological evaluations of N-methylated 76Br and 123I labeled amino acids for imaging of brain tumors
  • Radiolabeling, Characterization and Biodistribution study of Cysteine and its derivatives with Tc99m.
  • Catalytic Asymmetric 11C-Labeling of Native Tetrapeptide D-[11C]-Phe-D-Trp-L-Lys-L-Thr-OH as the Essential Pharmacophore for Somatostatin Imaging
Show more SPECIAL MTA: Novel Radiochemistry & Chelation Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire